American Capital Advisory’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238 Hold
3
﹤0.01% 1056
2026
Q1
$259 Buy
+3
New +$269 ﹤0.01% 997
2025
Q2
Sell
-5
Closed -$366 921
2025
Q1
$366 Buy
+5
New +$413 ﹤0.01% 569

Other funds holding GMED

American Capital Advisory's GMED Position: Q2 2026 in Review

American Capital Advisory held its Globus Medical (GMED) position steady in Q2 2026 at 3 shares worth $238. The position accounts for ﹤0.01% of the portfolio, ranked #1056.

American Capital Advisory first reported a position in GMED in Q1 2025 and has held it in 3 quarters since. The position peaked at $366 in Q1 2025. 182 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • American Capital Advisory held 3 shares of Globus Medical worth $238 as of Q2 2026.
  • American Capital Advisory left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #1056 holding.
  • American Capital Advisory first reported a position in Globus Medical in Q1 2025 and has held it in 3 quarters since.
  • American Capital Advisory's Globus Medical position peaked at $366 in Q1 2025.
  • 182 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.